Company Monitoring Page for Immunogen

latest headlines for company on cafepharma

Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
Tags:
breast cancer, aromatase inhibitors, AstraZeneca, Novartis, Femara, Arimidex, SERMs, Nolvadex, Roche, Herceptin, GSK, Tykerb, Xeloda, Perjeta, Kadcyla, Immunogen, Lymphoseek, Navidea Biopharmaceuticals, Nexavar, ONYX Pharmaceuticals
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Mon, 03/11/13 - 11:09 am
Tags:
Immunogen, trastuzumab, breast cancer
This FDA Approval Is Actually a Big Deal
Motley Fool
Wed, 02/27/13 - 12:40 pm
Tags:
Kadcyla, Roche, Immunogen
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Tags:
Roche, Immunogen, Repros Therapeutics, Chelsea Therapeutics, Gilead Sciences, Vivus
ImmunoGen Progresses with IMGN901
Yahoo/Zacks
Fri, 02/15/13 - 11:41 am
Tags:
Immunogen, IMGN901, small cell lung cancer
ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision
Seeking Alpha
Thu, 02/14/13 - 11:17 am
Tags:
Immunogen, FDA, trastuzumab, Roche
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Tags:
Theravance, GSK, Astellas, Vivus, Eli Lilly, Immunogen, Roche, M&A
Don't Worry About Immunogen's Disappointing Quarter
Motley Fool
Sat, 01/26/13 - 11:53 am
Tags:
Immunogen
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:39 am
Tags:
Vivus, Theravance, Roche, MAP Pharmaceuticals, M&A, Immunogen, GSK, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan
JPMorgan Healthcare Conference Highlights: ImmunoGen
Motley Fool
Tue, 01/8/13 - 10:24 am
Tags:
JPMHC 2013, Immunogen
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Tags:
Rytary, GSK, Impax Labs, Celgene, pomalidomide, Roche, T-DM1, Immunogen, Eliquis, Pfizer, Bristol-Myers Squibb, Biogen Idec, BG-12
ImmunoGen's Press Release Is More Than Mere News
Seeking Alpha
Tue, 12/4/12 - 01:33 pm
Tags:
Immunogen, Targeted Antibody Payload
ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thu, 11/8/12 - 12:07 pm
Tags:
Immunogen, Roche, T-DM1, breast cancer
Why ImmunoGen’s Shares Had a Bad Reaction
Motley Fool
Sat, 10/27/12 - 11:34 am
Tags:
Immunogen
ImmunoGen's CEO Discusses F1Q13 Results - Earnings Call Transcript
Seeking Alpha
Sat, 10/27/12 - 11:28 am
Tags:
Immunogen
ImmunoGen 1st-quarter grows by 29 pct as it studies lung cancer drug and other products
Yahoo/AP
Fri, 10/26/12 - 11:12 am
Tags:
earnings, Immunogen
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
Roche Hosts An Encouraging Investor Day
Seeking Alpha
Thu, 09/6/12 - 04:15 pm
Tags:
Roche, JNJ, Immunogen, Abbott Labs, Illumina
3 Things to Watch With ImmunoGen
Motley Fool
Wed, 08/29/12 - 12:13 pm
Tags:
Immunogen
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tue, 08/28/12 - 11:22 am
Tags:
breast cancer, Roche, Immunogen, T-DM1

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.